Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 32 (2) , 107884
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- National Institutes of Health (R01CA190415)
- National Institutes of Health (R01CA225929)
- National Institutes of Health (R01CA142776)
- National Institutes of Health (P50CA083638)
- National Institutes of Health (P50CA174523)
- Ovarian Cancer Research Alliance
- Foundation for Women's Cancer
This publication has 94 references indexed in Scilit:
- OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genesBioinformatics, 2013
- Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer driversMolecular Systems Biology, 2013
- The CDK Network: Linking Cycles of Cell Division and Gene ExpressionGenes & Cancer, 2012
- Landscape of transcription in human cellsNature, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- SomaticSniper: identification of somatic point mutations in whole genome sequencing dataBioinformatics, 2011
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Cyclin-dependent kinases: a family portraitNature Cell Biology, 2009
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009